How to Value a Pre-Seed or Seed Startup

Valuation is the part of fundraising founders most want a formula for — and the part that least resembles one at the earliest stage. There is a strong instinct to believe a pre-seed company has a "correct" value waiting to be calculated. It doesn't. At pre-seed and seed, valuation is the output of a negotiation, anchored on a handful of signals and bounded by what the market is doing that quarter.

That doesn't mean the number is arbitrary or that you're powerless. Understanding what actually moves an early-stage valuation — and what investors are really pricing — lets you set a number you can defend, raise the round you need, and avoid the traps that make the next round harder.

This guide covers why early valuations aren't math, the methods investors actually use, what sets your number in practice, and how to negotiate it without torching the relationship.

Why early-stage valuation isn't math

Valuation methods you'll read about — discounted cash flow, revenue multiples — all need numbers a pre-seed company doesn't have. There's no revenue to forecast, no margin history, often no product. Plugging zeros into a DCF gives you zero, which is useless. So investors fall back on something more honest: a price that reflects risk, ambition, and what comparable startups raised recently.

The mental model that helps most: a pre-seed valuation is mostly a function of how much you're raising and how much equity you're willing to give up. Investors at this stage typically want 10–20% of the company. If you raise $1M and give up 20%, that's a $5M post-money valuation. If you can defend giving up only 12.5%, the same $1M implies an $8M post-money. The "valuation" is largely downstream of those two decisions, not a separate calculation.

The methods investors actually use early

When there's no revenue to model, investors lean on a few pragmatic approaches. None is precise; together they triangulate a range.

The first and the fourth do most of the work at pre-seed. Comparables tell investors what the market is paying; dilution math tells them what they need to own. The scorecard and Berkus methods are mainly ways to justify nudging the comparable up or down based on your specific team and traction.

What actually sets your number

Within the range the market allows, a handful of factors push you toward the top or bottom:

• Team. A repeat founder with an exit, or a team with rare, relevant expertise, commands a premium. This is the single biggest lever pre-revenue. The same logic explains why building a strong founding team materially affects how investors price you.
• Traction. Any evidence the dog will eat the dog food — waitlist signups, pilot customers, early revenue, retention — compresses risk and lifts valuation. Coming in with real signal from getting your first customers changes the conversation.
• Market. A large, fast-growing, credible market supports a bigger outcome, which supports a bigger valuation. Investors price the size of the possible win.
• Competition for the deal. This is underrated. A round with three interested investors prices higher than one with a single lukewarm party. Valuation is partly a function of demand for your deal.
• The market cycle. Valuations move with the macro environment. The same company is worth more in a hot funding market than a cold one. You don't control this, but you should know where the cycle is when you set your ask.

10–20%

Pre-money, post-money, and the SAFE trap

You'll see two valuation numbers: pre-money (the value before the investment) and post-money (pre-money plus the new money). They're easy to confuse and the confusion is expensive.

Raise $1M at a $4M pre-money: post-money is $5M, investors own $1M / $5M = 20%. But if someone quotes "$4M post-money," that's a $3M pre-money, and the same $1M now buys 25%. Same headline, very different dilution.

This matters most with SAFEs. Modern SAFEs are post-money, which means the valuation cap is calculated after the SAFE money — and stacking several SAFEs can dilute founders far more than they expect, because each one's ownership is locked to the post-money cap. If you're raising on SAFEs, model the conversion before you sign. We cover the mechanics in depth in our guides to what a SAFE note is and reading your cap table.

How to negotiate valuation without losing the room

Once you understand the inputs, negotiation gets simpler. A few principles:

1. Anchor on comparables, not aspiration

   Walk in with 3–5 recent, genuinely comparable rounds (stage, sector, geography) and let them set the range. "Companies like us are raising at $6–8M post-money" is far stronger than a number you invented.

2. Lead with the round size, not the valuation

   Decide how much you need to hit your next milestone, then let valuation follow from acceptable dilution. "I'm raising $1.2M and giving up about 15%" is a clean, fundable framing.

3. Create competition

   Run a tight, time-boxed process so multiple investors are deciding at once. Genuine demand moves valuation more than any argument you can make.

4. Protect the next round

   Don't take the highest number if you can't grow into it. Ask yourself what metrics the next round will require and whether this valuation sets a bar you can clear in 12–18 months.

The terms around the valuation matter as much as the number — discounts, caps, board seats, pro-rata rights. Before you agree to anything, read our guide to what a term sheet is so you know which clauses are worth trading the valuation for.

The bottom line

At pre-seed and seed, stop hunting for a "correct" valuation and start managing the inputs you control: how much you raise, how much you'll dilute, the strength of your team and traction, and how competitive you make the deal. Anchor on comparables, frame the ask around round size, and never take a number so high you can't raise the next round on top of it.

If you're heading into a raise, the natural next reads are how to raise a seed round and, if you want to skip a priced round for now, how to raise a pre-seed round. And when you're ready to meet investors who fund teams at your stage, you can find startups and investors on Foundersbase.